Skip to main content
TipRanks
Go Ultimate75% OFF

TELA Bio (TELA) Stock Statistics & Valuation Metrics

177 Followers

Total Valuation

TELA Bio has a market cap or net worth of $34.44M. The enterprise value is $100.51M.

Market Cap
$34.44M
Enterprise Value
$100.51M

Share Statistics

TELA Bio has 45,188,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
45,188,230
Owned by Insiders
5.12%
Owned by Institutions
57.97%

Financial Efficiency

TELA Bio’s return on equity (ROE) is -6.15 and return on invested capital (ROIC) is -53.21%.

Return on Equity (ROE)
-6.15
Return on Assets (ROA)
-0.48
Return on Invested Capital (ROIC)
-53.21%
Return on Capital Employed (ROCE)
-0.53
Revenue Per Employee
368.23K
Profits Per Employee
-178.12K
Employee Count
218
Asset Turnover
0.99
Inventory Turnover
2.35

Valuation Ratios

The current PE Ratio of TELA Bio is -1.05. TELA Bio’s PEG ratio is -0.05.

PE Ratio
-1.05
PS Ratio
0.45
PB Ratio
-1.83
Price to FCF
-1.03
Price to Operating Cash Flow
-1.32
PEG Ratio
-0.05

Income Statement

In the last 12 months, TELA Bio had revenue of 80.28M and earned -38.83M in profits. Earnings per share was -0.83.

Revenue
80.28M
Gross Profit
54.34M
Operating Income
-33.76M
Pretax Income
-38.60M
Net Income
-38.83M
EBITDA
-32.35M
Earnings Per Share (EPS)
-0.83

Cash Flow

In the last 12 months, operating cash flow was -34.11M and capital expenditures -276,000, giving a free cash flow of -34.39M billion.

Operating Cash Flow
-34.11M
Free Cash Flow
-34.39M
Free Cash Flow per Share
-0.60

Dividends & Yields

TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-97.55%
Earnings Yield
-93.06%

Stock Price Statistics

Beta
0.96
52-Week Price Change
-33.90%
50-Day Moving Average
1.03
200-Day Moving Average
0.84
Relative Strength Index (RSI)
39.15
Average Volume (3m)
217.25K

Important Dates

TELA Bio upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

TELA Bio as a current ratio of 4.20, with Debt / Equity ratio of 881.56%

Current Ratio
4.20
Quick Ratio
3.59
Debt to Market Cap
1.00
Net Debt to EBITDA
-0.15
Interest Coverage Ratio
-6.44

Taxes

In the past 12 months, TELA Bio has paid 230.00K in taxes.

Income Tax
230.00K
Effective Tax Rate
-0.01

Enterprise Valuation

TELA Bio EV to EBITDA ratio is -2.09, with an EV/FCF ratio of -2.00.

EV to Sales
0.88
EV to EBITDA
-2.09
EV to Free Cash Flow
-2.00
EV to Operating Cash Flow
-2.02

Balance Sheet

TELA Bio has $22.66M in cash and marketable securities with $56.30M in debt, giving a net cash position of -$33.63M billion.

Cash & Marketable Securities
$22.66M
Total Debt
$56.30M
Net Cash
-$33.63M
Net Cash Per Share
-$0.74
Tangible Book Value Per Share
-$0.44

Margins

Gross margin is 67.19%, with operating margin of -43.17%, and net profit margin of -53.57%.

Gross Margin
67.19%
Operating Margin
-43.17%
Pretax Margin
-53.10%
Net Profit Margin
-53.57%
EBITDA Margin
-42.07%
EBIT Margin
-43.04%

Analyst Forecast

The average price target for TELA Bio is $1.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$1.75
Price Target Upside
124.36% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
1.46%
EPS Growth Forecast
15.79%

Scores

Smart Score
8
AI Score
48